{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:08:04Z","timestamp":1793326084174,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40257-015-0158-0","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T04:48:14Z","timestamp":1445316494000},"page":"475-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":193,"title":["Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis: An Update"],"prefix":"10.1007","volume":"16","author":[{"given":"Roni P.","family":"Dodiuk-Gad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Valeyrie-Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"issue":"6","key":"158_CR1","first-page":"526","volume":"24","author":"A Stevens","year":"1922","unstructured":"Stevens A, Johnson F. A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children. Arch Pediatr Adolesc Med. 1922;24(6):526.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"158_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"A Lyell","year":"1956","unstructured":"Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68(11):355\u201361.","journal-title":"Br J Dermatol"},{"issue":"5","key":"158_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1529-8019.2009.01260.x","volume":"22","author":"S Knowles","year":"2009","unstructured":"Knowles S, Shear NH. Clinical risk management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis spectrum. Dermatol Ther. 2009;22(5):441\u201351.","journal-title":"Dermatol Ther"},{"issue":"9","key":"158_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","volume":"123","author":"JC Roujeau","year":"1987","unstructured":"Roujeau JC, Huynh TN, Bracq C, et al. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987;123(9):1171\u20133.","journal-title":"Arch Dermatol"},{"issue":"6982","key":"158_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens\u2013Johnson syndrome. Nature. 2004;428(6982):486.","journal-title":"Nature."},{"issue":"12","key":"158_CR6","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia. 2010;51(12):2461\u20135.","journal-title":"Epilepsia."},{"issue":"1\u20132","key":"158_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res. 2011;97(1\u20132):190\u20137.","journal-title":"Epilepsy Res"},{"issue":"1","key":"158_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","volume":"111","author":"YW Shi","year":"2012","unstructured":"Shi YW, Min FL, Qin B, et al. Association between HLA and Stevens\u2013Johnson syndrome induced by carbamazepine in southern Han Chinese: genetic markers besides B*1502? Basic Clin Pharmacol Toxicol. 2012;111(1):58\u201364.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"158_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","volume":"73","author":"YH Hsiao","year":"2014","unstructured":"Hsiao YH, Hui RC, Wu T, et al. Genotype\u2013phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. Journal of dermatological science. 2014;73(2):101\u20139.","journal-title":"Journal of dermatological science."},{"issue":"11","key":"158_CR10","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","volume":"9","author":"N Kaniwa","year":"2008","unstructured":"Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics. 2008;9(11):1617\u201322.","journal-title":"Pharmacogenomics."},{"issue":"5","key":"158_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","volume":"21","author":"HR Kang","year":"2011","unstructured":"Kang HR, Jee YK, Kim YS, et al. Positive and negative associations of HLA class\u00a0I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics. 2011;21(5):303\u20137.","journal-title":"Pharmacogenet Genomics."},{"issue":"9","key":"158_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","volume":"19","author":"W Tassaneeyakul","year":"2009","unstructured":"Tassaneeyakul W, Jantararoungtong T, Chen P, et al. Strong association between HLA-B*5801 and allopurinol-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics. 2009;19(9):704\u20139.","journal-title":"Pharmacogenet Genomics."},{"issue":"11","key":"158_CR13","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"158_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","volume":"51","author":"H Ikeda","year":"2010","unstructured":"Ikeda H, Takahashi Y, Yamazaki E, et al. HLA class\u00a0I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia. 2010;51(2):297\u2013300.","journal-title":"Epilepsia."},{"issue":"7","key":"158_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1346-8138.2011.01457.x","volume":"39","author":"H Niihara","year":"2012","unstructured":"Niihara H, Kakamu T, Fujita Y, et al. HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population. J Dermatol. 2012;39(7):594\u2013601.","journal-title":"J Dermatol"},{"issue":"5","key":"158_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet. 2011;20(5):1034\u201341.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"158_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/epi.12217","volume":"54","author":"YK Cheung","year":"2013","unstructured":"Cheung YK, Cheng SH, Chan EJ, et al. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013;54(7):1307\u201314.","journal-title":"Epilepsia."},{"issue":"3","key":"158_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/pgs.09.162","volume":"11","author":"SI Hung","year":"2010","unstructured":"Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics. 2010;11(3):349\u201356.","journal-title":"Pharmacogenomics."},{"issue":"12","key":"158_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens\u2013Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia. 2008;49(12):2087\u201391.","journal-title":"Epilepsia."},{"issue":"6","key":"158_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2217\/pgs.10.54","volume":"11","author":"SH Kim","year":"2010","unstructured":"Kim SH, Kim M, Lee KW, et al. HLA-B*5901 is strongly associated with methazolamide-induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Pharmacogenomics. 2010;11(6):879\u201384.","journal-title":"Pharmacogenomics."},{"issue":"2","key":"158_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, et al. A European study of HLA-B in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics. 2008;18(2):99\u2013107.","journal-title":"Pharmacogenet Genomics."},{"issue":"6","key":"158_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B, et al. Association of HLA-B*1502 allele and carbamazepine-induced Stevens\u2013Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol. 2009;75(6):579\u201382.","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"9","key":"158_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","volume":"149","author":"W Tangamornsuksan","year":"2013","unstructured":"Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, et al. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2013;149(9):1025\u201332.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"158_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jdermsci.2012.04.002","volume":"66","author":"WH Chung","year":"2012","unstructured":"Chung WH, Hung SI. Recent advances in the genetics and immunology of Stevens\u2013Johnson syndrome and toxic epidermal necrosis. J Dermatol Sci. 2012;66(3):190\u20136.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"158_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med. 2011;364(12):1126\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"158_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/clpt.2012.209","volume":"93","author":"MS Hershfield","year":"2013","unstructured":"Hershfield MS, Callaghan JT, Tassaneeyakul W, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing. Clin Pharmacol Ther. 2013;93(2):153\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"158_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2014","unstructured":"Genin E, Chen DP, Hung SI, et al. HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J. 2014;14(3):281\u20138.","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"158_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1172\/JCI113798","volume":"82","author":"NH Shear","year":"1988","unstructured":"Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Investig. 1988;82(6):1826\u201332.","journal-title":"J Clin Investig"},{"issue":"2","key":"158_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","volume":"105","author":"NH Shear","year":"1986","unstructured":"Shear NH, Spielberg SP, Grant DM, et al. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986;105(2):179\u201384.","journal-title":"Ann Intern Med"},{"issue":"5","key":"158_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.7859","volume":"312","author":"WH Chung","year":"2014","unstructured":"Chung WH, Chang WC, Lee YS, et al. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA. 2014;312(5):525\u201334.","journal-title":"JAMA."},{"issue":"7","key":"158_CR31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00228-010-0817-2","volume":"66","author":"R Kesavan","year":"2010","unstructured":"Kesavan R, Narayan SK, Adithan C. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients. Eur J Clin Pharmacol. 2010;66(7):689\u201396.","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"158_CR32","first-page":"1159","volume":"18","author":"C Depondt","year":"2011","unstructured":"Depondt C, Godard P, Espel RS, et al. A candidate gene study of antiepileptic drug tolerability and efficacy identifies an association of CYP2C9 variants with phenytoin toxicity. Eur J Neurol Off J Eur Fed Neurol Soc. 2011;18(9):1159\u201364.","journal-title":"Eur J Neurol Off J Eur Fed Neurol Soc"},{"issue":"11","key":"158_CR33","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00228-013-1549-x","volume":"69","author":"C Ciccacci","year":"2013","unstructured":"Ciccacci C, Di Fusco D, Marazzi MC, et al. Association between CYP2B6 polymorphisms and nevirapine-induced SJS\/TEN: a pharmacogenetics study. Eur J Clin Pharmacol. 2013;69(11):1909\u201316.","journal-title":"Eur J Clin Pharmacol."},{"issue":"5","key":"158_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00130832-200410000-00013","volume":"4","author":"M Lerch","year":"2004","unstructured":"Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol. 2004;4(5):411\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"158_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","volume":"2","author":"WJ Pichler","year":"2002","unstructured":"Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol. 2002;2(4):301\u20135.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"158_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","volume":"120","author":"CW Yang","year":"2007","unstructured":"Yang CW, Hung SI, Juo CG, et al. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens\u2013Johnson syndrome. J Allergy Clin Immunol. 2007;120(4):870\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"158_CR37","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW, et al. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens\u2013Johnson syndrome. J Allergy Clin Immunol. 2012;129(6):1562\u20139 (e5).","journal-title":"J Allergy Clin Immunol."},{"issue":"Suppl 4","key":"158_CR38","first-page":"25","volume":"28","author":"MJ Torres","year":"1998","unstructured":"Torres MJ, Mayorga C, Garcia JJ, et al. New aspects in betalactam recognition. Clin Exp Allergy. 1998;28(Suppl 4):25\u20138.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"158_CR39","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","volume":"128","author":"TM Ko","year":"2011","unstructured":"Ko TM, Chung WH, Wei CY, et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens\u2013Johnson syndrome. J Allergy Clin Immunol. 2011;128(6):1266\u201376 (e11).","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"158_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1067\/mai.2002.120563","volume":"109","author":"SJ Posadas","year":"2002","unstructured":"Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme\u00a0B, and Fas-L to be related to disease severity. J Allergy Clin Immunol. 2002;109(1):155\u201361.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"158_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","volume":"123","author":"A Nassif","year":"2004","unstructured":"Nassif A, Moslehi H, Le Gouvello S, et al. Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Investig Dermatol. 2004;123(5):850\u20135.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"158_CR42","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","volume":"155","author":"M Caproni","year":"2006","unstructured":"Caproni M, Torchia D, Schincaglia E, et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Br J Dermatol. 2006;155(4):722\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"158_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.cr.7290259","volume":"15","author":"ZG Liu","year":"2005","unstructured":"Liu ZG. Molecular mechanism of TNF signaling and beyond. Cell Res. 2005;15(1):24\u20137.","journal-title":"Cell Res"},{"issue":"1","key":"158_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cmi.2009.3","volume":"6","author":"L Chavez-Galan","year":"2009","unstructured":"Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, et al. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol. 2009;6(1):15\u201325.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"158_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163\u201389.","journal-title":"J Leukoc Biol"},{"issue":"5168","key":"158_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist CA, Mottet A, et al. Regulation of MHC class\u00a0II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994;265(5168):106\u20139.","journal-title":"Science."},{"issue":"1","key":"158_CR47","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0952-7915(99)80014-4","volume":"11","author":"K Fruh","year":"1999","unstructured":"Fruh K, Yang Y. Antigen presentation by MHC class\u00a0I and its regulation by interferon gamma. Curr Opin Immunol. 1999;11(1):76\u201381.","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"158_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","volume":"22","author":"P Paquet","year":"2000","unstructured":"Paquet P, Paquet F, Al Saleh W, et al. Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis. Am J Dermatopathol. 2000;22(5):413\u20137.","journal-title":"Am J Dermatopathol."},{"issue":"1","key":"158_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1067\/mjd.2002.120473","volume":"47","author":"O Correia","year":"2002","unstructured":"Correia O, Delgado L, Barbosa IL, et al. Increased interleukin\u00a010, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis. J Am Acad Dermatol. 2002;47(1):58\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"158_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2004.04.034","volume":"114","author":"B Tapia","year":"2004","unstructured":"Tapia B, Padial A, Sanchez-Sabate E, et al. Involvement of CCL27\u2013CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol. 2004;114(2):335\u201340.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"158_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2332\/allergolint.10-RAI-0261","volume":"59","author":"WH Chung","year":"2010","unstructured":"Chung WH, Hung SI. Genetic markers and danger signals in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Allergol Int. 2010;59(4):325\u201332.","journal-title":"Allergol Int."},{"issue":"12","key":"158_CR52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008;14(12):1343\u201350.","journal-title":"Nat Med"},{"issue":"5388","key":"158_CR53","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 1998;282(5388):490\u20133.","journal-title":"Science."},{"issue":"4","key":"158_CR54","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","volume":"118","author":"A Nassif","year":"2002","unstructured":"Nassif A, Bensussan A, Dorothee G, et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Investig Dermatol. 2002;118(4):728\u201333.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"158_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jaci.2013.04.036","volume":"132","author":"CW Wang","year":"2013","unstructured":"Wang CW, Chung WH, Cheng YF, et al. A new nucleic acid\u2013based agent inhibits cytotoxic T\u00a0lymphocyte-mediated immune disorders. J Allergy Clin Immunol. 2013;132(3):713\u201322 (e11).","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"158_CR56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pep.2010.07.009","volume":"75","author":"MW Finn","year":"2011","unstructured":"Finn MW, Clayberger C, Krensky AM. Expression and purification of 15\u00a0kDa granulysin utilizing an insect cell secretion system. Protein Expr Purif. 2011;75(1):70\u20134.","journal-title":"Protein Expr Purif"},{"issue":"18","key":"158_CR57","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood-2010-03-273953","volume":"116","author":"P Tewary","year":"2010","unstructured":"Tewary P, Yang D, de la Rosa G, et al. Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood. 2010;116(18):3465\u201374.","journal-title":"Blood."},{"issue":"11","key":"158_CR58","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1398-9995.2011.02677.x","volume":"66","author":"C Schlapbach","year":"2011","unstructured":"Schlapbach C, Zawodniak A, Irla N, et al. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions. Allergy. 2011;66(11):1469\u201376.","journal-title":"Allergy."},{"issue":"6","key":"158_CR59","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02113442","volume":"14","author":"S Fournier","year":"1995","unstructured":"Fournier S, Bastuji-Garin S, Mentec H, et al. Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis. 1995;14(6):558\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"158_CR60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0310057X0703500317","volume":"35","author":"JM Mulvey","year":"2007","unstructured":"Mulvey JM, Padowitz A, Lindley-Jones M, et al. Mycoplasma pneumoniae associated with Stevens Johnson syndrome. Anaesth Intensive Care. 2007;35(3):414\u20137.","journal-title":"Anaesth Intensive Care"},{"key":"158_CR61","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. Orphanet J Rare Dis. 2010;5:39.","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"158_CR62","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/infdis\/jit383","volume":"208","author":"WH Chung","year":"2013","unstructured":"Chung WH, Shih SR, Chang CF, et al. Clinicopathologic analysis of coxsackievirus\u00a0a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis. 2013;208(12):1968\u201378.","journal-title":"J Infect Dis"},{"issue":"7","key":"158_CR63","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","volume":"49","author":"B Rzany","year":"1996","unstructured":"Rzany B, Mockenhaupt M, Baur S, et al. Epidemiology of erythema exsudativum multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis in Germany (1990\u20131992): structure and results of a population-based registry. Journal of clinical epidemiology. 1996;49(7):769\u201373.","journal-title":"Journal of clinical epidemiology."},{"issue":"6","key":"158_CR64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","volume":"7","author":"M Mockenhaupt","year":"2011","unstructured":"Mockenhaupt M. The current understanding of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Expert review of clinical immunology. 2011;7(6):803\u201313 (quiz 14\u20135).","journal-title":"Expert review of clinical immunology."},{"issue":"1","key":"158_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Investig Dermatol. 2008;128(1):35\u201344.","journal-title":"J Investig Dermatol"},{"issue":"12","key":"158_CR66","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0929-6646(08)60079-0","volume":"106","author":"LY Huang","year":"2007","unstructured":"Huang LY, Liao WC, Chiou CC, et al. Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens\u2013Johnson syndrome. J Formos Med Assoc Taiwan yi Zhi. 2007;106(12):1032\u20137.","journal-title":"J Formos Med Assoc Taiwan yi Zhi"},{"issue":"8","key":"158_CR67","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens\u2013Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019\u201324.","journal-title":"Arch Dermatol"},{"issue":"5","key":"158_CR68","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","volume":"131","author":"H Assier","year":"1995","unstructured":"Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement and Stevens\u2013Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol. 1995;131(5):539\u201343.","journal-title":"Arch Dermatol."},{"issue":"1","key":"158_CR69","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129(1):92\u20136.","journal-title":"Arch Dermatol."},{"issue":"9","key":"158_CR70","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","volume":"123","author":"J Revuz","year":"1987","unstructured":"Revuz J, Penso D, Roujeau JC, et al. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987;123(9):1160\u20135.","journal-title":"Arch Dermatol."},{"issue":"8","key":"158_CR71","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","volume":"35","author":"R Rajaratnam","year":"2010","unstructured":"Rajaratnam R, Mann C, Balasubramaniam P, et al. Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clin Exp Dermatol. 2010;35(8):853\u201362.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"158_CR72","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0029-7844(97)00596-6","volume":"91","author":"E Meneux","year":"1998","unstructured":"Meneux E, Wolkenstein P, Haddad B, et al. Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases. Obstet Gynecol. 1998;91(2):283\u20137.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"158_CR73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1001\/archdermatol.2009.540","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry J, Roujeau JC, Binaghi M, et al. Risk factors for the development of ocular complications of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145(2):157\u201362.","journal-title":"Arch Dermatol."},{"issue":"4","key":"158_CR74","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","volume":"116","author":"C Sotozono","year":"2009","unstructured":"Sotozono C, Ueta M, Koizumi N, et al. Diagnosis and treatment of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009;116(4):685\u201390.","journal-title":"Ophthalmology."},{"issue":"2","key":"158_CR75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","volume":"56","author":"FA Pereira","year":"2007","unstructured":"Pereira FA, Mudgil AV, Rosmarin DM. Toxic epidermal necrolysis. J Am Acad Dermatol. 2007;56(2):181\u2013200.","journal-title":"J Am Acad Dermatol."},{"issue":"12","key":"158_CR76","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001340050492","volume":"23","author":"F Lebargy","year":"1997","unstructured":"Lebargy F, Wolkenstein P, Gisselbrecht M, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive care Med. 1997;23(12):1237\u201344.","journal-title":"Intensive care Med."},{"issue":"1","key":"158_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","volume":"42","author":"N de Prost","year":"2014","unstructured":"de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, et al. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med. 2014;42(1):118\u201328.","journal-title":"Crit Care Med"},{"issue":"10","key":"158_CR78","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/BF01296123","volume":"38","author":"P Michel","year":"1993","unstructured":"Michel P, Joly P, Ducrotte P, et al. Ileal involvement in toxic epidermal necrolysis (Lyell syndrome). Dig Dis Sci. 1993;38(10):1938\u201341.","journal-title":"Dig Dis Sci"},{"issue":"968","key":"158_CR79","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1136\/pgmj.2005.042952","volume":"82","author":"N Powell","year":"2006","unstructured":"Powell N, Munro JM, Rowbotham D. Colonic involvement in Stevens\u2013Johnson syndrome. Postgrad Med J. 2006;82(968):e10.","journal-title":"Postgrad Med J"},{"issue":"6","key":"158_CR80","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000195632","volume":"29","author":"CC Hung","year":"2009","unstructured":"Hung CC, Liu WC, Kuo MC, et al. Acute renal failure and its risk factors in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Am J Nephrol. 2009;29(6):633\u20138.","journal-title":"Am J Nephrol"},{"issue":"7","key":"158_CR81","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.burns.2013.03.011","volume":"39","author":"C Weinand","year":"2013","unstructured":"Weinand C, Xu W, Perbix W, et al. 27 years of a single burn centre experience with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents. Burns. 2013;39(7):1449\u201355.","journal-title":"Burns."},{"issue":"1","key":"158_CR82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","volume":"89","author":"N de Prost","year":"2010","unstructured":"de Prost N, Ingen-Housz-Oro S, Duong T, et al. Bacteremia in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures. Medicine (Baltimore). 2010;89(1):28\u201336.","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"158_CR83","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, et al. Comprehensive survival analysis of a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Investig Dermatol. 2013;133(5):1197\u2013204.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"158_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archderm.136.3.323","volume":"136","author":"I Garcia-Doval","year":"2000","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H, et al. Toxic epidermal necrolysis and Stevens\u2013Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000;136(3):323\u20137.","journal-title":"Arch Dermatol."},{"issue":"2","key":"158_CR85","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115(2):149\u201353.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"158_CR86","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1097\/BCR.0b013e318254d2ec","volume":"33","author":"QY Zhu","year":"2012","unstructured":"Zhu QY, Ma L, Luo XQ, et al. Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China. J Burn Care Res. 2012;33(6):e295\u2013308.","journal-title":"J Burn Care Res."},{"issue":"1","key":"158_CR87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","volume":"29","author":"R Cartotto","year":"2008","unstructured":"Cartotto R, Mayich M, Nickerson D, et al. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center. J Burn Care Res. 2008;29(1):141\u20136.","journal-title":"J Burn Care Res"},{"issue":"2","key":"158_CR88","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","volume":"32","author":"P Sekula","year":"2011","unstructured":"Sekula P, Liss Y, Davidovici B, et al. Evaluation of SCORTEN on a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study. J Burn Care Res. 2011;32(2):237\u201345.","journal-title":"J Burn Care Res."},{"issue":"2","key":"158_CR89","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.jid.5700068","volume":"126","author":"S Guegan","year":"2006","unstructured":"Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, et al. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Investig Dermatol. 2006;126(2):272\u20136.","journal-title":"J Investig Dermatol"},{"issue":"2","key":"158_CR90","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.annder.2010.10.029","volume":"138","author":"A Fellahi","year":"2011","unstructured":"Fellahi A, Zouhair K, Amraoui A, et al. Stevens\u2013Johnson and Lyell syndromes: mucocutaneous and ocular sequels in 43 cases [in French]. Ann Dermatol Venereol. 2011;138(2):88\u201392.","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"158_CR91","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","volume":"150","author":"ME Morales","year":"2010","unstructured":"Morales ME, Purdue GF, Verity SM, et al. Ophthalmic manifestations of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN. Am J Ophthalmol. 2010;150(4):505\u201310 (e1).","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"158_CR92","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/archdermatol.2009.233","volume":"145","author":"F Gaultier","year":"2009","unstructured":"Gaultier F, Rochefort J, Landru MM, et al. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol. 2009;145(11):1332\u20133.","journal-title":"Arch Dermatol."},{"issue":"2","key":"158_CR93","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bjd.13505","volume":"172","author":"TA Duong","year":"2015","unstructured":"Duong TA, de Prost N, Ingen-Housz-Oro S, et al. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission. Br J Dermatol. 2015;172(2):400\u20135.","journal-title":"Br J Dermatol"},{"key":"158_CR94","unstructured":"Dodiuk-Gad RP, Olteanu C, Hashimoto R, et al. Long-term emotional and physical complications of Stevens\u2013Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). 23rd World Congress of Dermatology; Vancouver; 2015."},{"issue":"6","key":"158_CR95","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archderm.141.6.683","volume":"141","author":"AM Quinn","year":"2005","unstructured":"Quinn AM, Brown K, Bonish BK, et al. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol. 2005;141(6):683\u20137.","journal-title":"Arch Dermatol."},{"issue":"1","key":"158_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jaad.2010.04.042","volume":"65","author":"Y Fujita","year":"2011","unstructured":"Fujita Y, Yoshioka N, Abe R, et al. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol. 2011;65(1):65\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"158_CR97","first-page":"278","volume":"2","author":"S Nigen","year":"2003","unstructured":"Nigen S, Knowles SR, Shear NH. Drug eruptions: approaching the diagnosis of drug-induced skin diseases. J Drugs Dermatol. 2003;2(3):278\u201399.","journal-title":"J Drugs Dermatol."},{"issue":"2","key":"158_CR98","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/120347540000400211","volume":"4","author":"ER Eisen","year":"2000","unstructured":"Eisen ER, Fish J, Shear NH. Management of drug-induced toxic epidermal necrolysis. J Cutan Med Surg. 2000;4(2):96\u2013102.","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"158_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12788\/j.sder.0058","volume":"33","author":"M Mockenhaupt","year":"2014","unstructured":"Mockenhaupt M. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management. Semin Cutan Med Surg. 2014;33(1):10\u20136.","journal-title":"Semin Cutan Med Surg"},{"issue":"2","key":"158_CR100","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1529-8019.2011.01397.x","volume":"24","author":"R Chavan","year":"2011","unstructured":"Chavan R, el-Azhary R. Cutaneous graft-versus-host disease: rationales and treatment options. Dermatol Ther. 2011;24(2):219\u201328.","journal-title":"Dermatol Ther."},{"issue":"4","key":"158_CR101","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1067\/mjd.2003.107","volume":"48","author":"R Mandelcorn","year":"2003","unstructured":"Mandelcorn R, Shear NH. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? J Am Acad Dermatol. 2003;48(4):525\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"158_CR102","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0961203307079498","volume":"16","author":"S Paradela","year":"2007","unstructured":"Paradela S, Martinez-Gomez W, Fernandez-Jorge B, et al. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus. Lupus. 2007;16(9):741\u20135.","journal-title":"Lupus."},{"issue":"7","key":"158_CR103","first-page":"837","volume":"9","author":"BT Baldwin","year":"2010","unstructured":"Baldwin BT, Lien MH, Khan H, et al. Case of fatal toxic epidermal necrolysis due to cardiac catheterization dye. J Drugs Dermatol. 2010;9(7):837\u201340.","journal-title":"J Drugs Dermatol."},{"issue":"2","key":"158_CR104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00006454-200102000-00022","volume":"20","author":"R Ball","year":"2001","unstructured":"Ball R, Ball LK, Wise RP, et al. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr Infect Dis J. 2001;20(2):219\u201323.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"158_CR105","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al. ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: comparison with case\u2013control analysis. Clin Pharmacol Ther. 2010;88(1):60\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"158_CR106","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40272-013-0039-z","volume":"15","author":"K Heelan","year":"2013","unstructured":"Heelan K, Shear NH. Cutaneous drug reactions in children: an update. Paediatr Drugs. 2013;15(6):493\u2013503.","journal-title":"Paediatr Drugs."},{"issue":"1","key":"158_CR107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaip.2013.11.005","volume":"2","author":"R Pavlos","year":"2014","unstructured":"Pavlos R, Mallal S, Ostrov D, et al. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy. J Allergy Clin Immunol Pract. 2014;2(1):21\u201333.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"158_CR108","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809\u201320.","journal-title":"Allergy."},{"issue":"9","key":"158_CR109","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/cea.12145","volume":"43","author":"G Porebski","year":"2013","unstructured":"Porebski G, Pecaric-Petkovic T, Groux-Keller M, et al. In vitro drug causality assessment in Stevens\u2013Johnson syndrome\u2014alternatives for lymphocyte transformation test. Clin Exp Allergy. 2013;43(9):1027\u201337.","journal-title":"Clin Exp Allergy."},{"key":"158_CR110","doi-asserted-by":"crossref","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part\u00a0I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013;69(2):173 e1\u201313 (quiz 85\u20136).","DOI":"10.1016\/j.jaad.2013.05.003"},{"issue":"2","key":"158_CR111","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.jaad.2011.10.007","volume":"68","author":"L Valeyrie-Allanore","year":"2013","unstructured":"Valeyrie-Allanore L, Bastuji-Garin S, Guegan S, et al. Prognostic value of histologic features of toxic epidermal necrolysis. J Am Acad Dermatol. 2013;68(2):e29\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"158_CR112","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","volume":"29","author":"FW Endorf","year":"2008","unstructured":"Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res. 2008;29(5):706\u201312.","journal-title":"J Burn Care Res."},{"issue":"10","key":"158_CR113","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","volume":"46","author":"JS Fromowitz","year":"2007","unstructured":"Fromowitz JS, Ramos-Caro FA, Flowers FP, et al. Practical guidelines for the management of toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. Int J Dermatol. 2007;46(10):1092\u20134.","journal-title":"Int J Dermatol."},{"issue":"4","key":"158_CR114","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.dsi.2013.09.008","volume":"31","author":"L Valeyrie-Allanore","year":"2013","unstructured":"Valeyrie-Allanore L, Ingen-Housz-Oro S, Chosidow O, et al. French referral center management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Dermatol Sin. 2013;31(4):191\u20135.","journal-title":"Dermatol Sin"},{"issue":"1","key":"158_CR115","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/BCR.0b013e3181cb8cb8","volume":"31","author":"S Shiga","year":"2010","unstructured":"Shiga S, Cartotto R. What are the fluid requirements in toxic epidermal necrolysis? J Burn Care Res. 2010;31(1):100\u20134.","journal-title":"J Burn Care Res."},{"issue":"3","key":"158_CR116","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","volume":"53","author":"SL Fernando","year":"2012","unstructured":"Fernando SL. The management of toxic epidermal necrolysis. Australas J Dermatol. 2012;53(3):165\u201371.","journal-title":"Australas J Dermatol"},{"issue":"5","key":"158_CR117","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0884533608323434","volume":"23","author":"T Mayes","year":"2008","unstructured":"Mayes T, Gottschlich M, Khoury J, et al. Energy requirements of pediatric patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Nutr Clin Pract. 2008;23(5):547\u201350.","journal-title":"Nutr Clin Pract."},{"issue":"1","key":"158_CR118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau JC. Intravenous immunoglobulin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139(1):33\u20136.","journal-title":"Arch Dermatol."},{"issue":"15","key":"158_CR119","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","volume":"65","author":"O Faye","year":"2005","unstructured":"Faye O, Roujeau JC. Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV\u00a0Ig): clinical experience to date. Drugs. 2005;65(15):2085\u201390.","journal-title":"Drugs."},{"issue":"6","key":"158_CR120","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/bjd.12607","volume":"169","author":"HY Lee","year":"2013","unstructured":"Lee HY, Lim YL, Thirumoorthy T, et al. The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre. Br J Dermatol. 2013;169(6):1304\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"158_CR121","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, et al. Open trial of ciclosporin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2010;163(4):847\u201353.","journal-title":"Br J Dermatol"},{"issue":"3","key":"158_CR122","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"JM Arevalo","year":"2000","unstructured":"Arevalo JM, Lorente JA, Gonzalez-Herrada C, et al. Treatment of toxic epidermal necrolysis with cyclosporin\u00a0A. J Trauma. 2000;48(3):473\u20138.","journal-title":"J Trauma."},{"issue":"5","key":"158_CR123","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","volume":"71","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof MG, Miliszewski MA, Sikora S, et al. Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol. 2014;71(5):941\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"158_CR124","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","volume":"58","author":"J Schneck","year":"2008","unstructured":"Schneck J, Fagot JP, Sekula P, et al. Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol. 2008;58(1):33\u201340.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"158_CR125","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40264-014-0165-8","volume":"37","author":"RP Dodiuk-Gad","year":"2014","unstructured":"Dodiuk-Gad RP, Chung WH, Yang CH, et al. The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions. Drug Saf. 2014;37(6):459\u201364.","journal-title":"Drug Saf."},{"issue":"2","key":"158_CR126","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0214","volume":"87","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Acta dermato-venereol. 2007;87(2):144\u20138.","journal-title":"Acta dermato-venereol."},{"issue":"4","key":"158_CR127","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/pde.12029","volume":"31","author":"V Scott-Lang","year":"2014","unstructured":"Scott-Lang V, Tidman M, McKay D. Toxic epidermal necrolysis in a child successfully treated with infliximab. Pediatr Dermatol. 2014;31(4):532\u20134.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"158_CR128","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","volume":"36","author":"E Gubinelli","year":"2009","unstructured":"Gubinelli E, Canzona F, Tonanzi T, et al. Toxic epidermal necrolysis successfully treated with etanercept. J Dermatol. 2009;36(3):150\u20133.","journal-title":"J Dermatol"},{"issue":"2","key":"158_CR129","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Abeni D, Bergamo F, et al. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol. 2014;71(2):278\u201383.","journal-title":"J Am Acad Dermatol"},{"key":"158_CR130","first-page":"e121","volume":"18","author":"BR Del Pozzo-Magana","year":"2011","unstructured":"Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, et al. A systematic review of treatment of drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children. J Popul Ther Clin Pharmacol. 2011;18:e121\u201333.","journal-title":"J Popul Ther Clin Pharmacol."},{"issue":"1","key":"158_CR131","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaad.2009.06.085","volume":"62","author":"MJ Koh","year":"2010","unstructured":"Koh MJ, Tay YK. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Asian children. J Am Acad Dermatol. 2010;62(1):54\u201360.","journal-title":"J Am Acad Dermatol."},{"issue":"6","key":"158_CR132","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1097\/BCR.0b013e31827a2ac3","volume":"34","author":"GM Hamilton","year":"2013","unstructured":"Hamilton GM, Fish J. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit. J Burn Care Res. 2013;34(6):e351\u20138.","journal-title":"J Burn Care Res."},{"issue":"15","key":"158_CR133","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1517\/14656566.2010.515587","volume":"11","author":"P Paquet","year":"2010","unstructured":"Paquet P, Pierard GE. Topical treatment options for drug-induced toxic epidermal necrolysis (TEN). Expert Opin Pharmacother. 2010;11(15):2447\u201358.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"158_CR134","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bjps.2014.04.003","volume":"67","author":"C Abela","year":"2014","unstructured":"Abela C, Hartmann CE, De Leo A, et al. Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm. J Plast Reconstr Aesthet Surg. 2014;67(8):1026\u201332.","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"4","key":"158_CR135","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1542-0124(12)70234-3","volume":"8","author":"Y Fu","year":"2010","unstructured":"Fu Y, Gregory DG, Sippel KC, et al. The ophthalmologist\u2019s role in the management of acute Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Ocul Surf. 2010;8(4):193\u2013203.","journal-title":"Ocul Surf."},{"issue":"6","key":"158_CR136","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.survophthal.2009.03.004","volume":"54","author":"E Shay","year":"2009","unstructured":"Shay E, Kheirkhah A, Liang L, et al. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Surv Ophthalmol. 2009;54(6):686\u201396.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"158_CR137","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/ICO.0b013e31823d02a8","volume":"31","author":"M Hsu","year":"2012","unstructured":"Hsu M, Jayaram A, Verner R, et al. Indications and outcomes of amniotic membrane transplantation in the management of acute Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a case\u2013control study. Cornea. 2012;31(12):1394\u2013402.","journal-title":"Cornea."},{"issue":"3","key":"158_CR138","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/ICO.0b013e318243fee3","volume":"32","author":"PJ Tomlins","year":"2013","unstructured":"Tomlins PJ, Parulekar MV, Rauz S. \u201cTriple-TEN\u201d in the treatment of acute ocular complications from toxic epidermal necrolysis. Cornea. 2013;32(3):365\u20139.","journal-title":"Cornea."},{"issue":"3","key":"158_CR139","first-page":"153","volume":"42","author":"E Meneux","year":"1997","unstructured":"Meneux E, Paniel BJ, Pouget F, et al. Vulvovaginal sequelae in toxic epidermal necrolysis. J Reprod Med. 1997;42(3):153\u20136.","journal-title":"J Reprod Med"},{"issue":"5","key":"158_CR140","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00404-009-1008-1","volume":"280","author":"IC Niemeijer","year":"2009","unstructured":"Niemeijer IC, van Praag MC, van Gemund N. Relevance and consequences of erythema multiforme, Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in gynecology. Arch Gynecol Obstet. 2009;280(5):851\u20134.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"158_CR141","first-page":"81","volume":"4","author":"DJ Kaser","year":"2011","unstructured":"Kaser DJ, Reichman DE, Laufer MR. Prevention of vulvovaginal sequelae in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Rev Obstet Gynecol. 2011;4(2):81\u20135.","journal-title":"Rev Obstet Gynecol."},{"issue":"5","key":"158_CR142","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/BCR.0b013e3181eed441","volume":"31","author":"MF Struck","year":"2010","unstructured":"Struck MF, Illert T, Liss Y, et al. Toxic epidermal necrolysis in pregnancy: case report and review of the literature. J Burn Care Res. 2010;31(5):816\u201321.","journal-title":"J Burn Care Res."},{"issue":"5 Suppl","key":"158_CR143","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.jaad.2005.09.021","volume":"55","author":"G Rodriguez","year":"2006","unstructured":"Rodriguez G, Trent JT, Mirzabeigi M, et al. Toxic epidermal necrolysis in a mother and fetus. J Am Acad Dermatol. 2006;55(5 Suppl):S96\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"158_CR144","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1159\/000017950","volume":"196","author":"N Claessens","year":"1998","unstructured":"Claessens N, Delbeke L, Lambert J, et al. Toxic epidermal necrolysis associated with treatment for preterm labor. Dermatology. 1998;196(4):461\u20132.","journal-title":"Dermatology."},{"issue":"2","key":"158_CR145","first-page":"225","volume":"12","author":"AI Vasicka","year":"1958","unstructured":"Vasicka AI, Lin TJ, Das BK. Erythema multiforme exudativum (Stevens\u2013Johnson syndrome) at term pregnancy: report of one case. Obstet Gynecol. 1958;12(2):225\u20139.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"158_CR146","doi-asserted-by":"publisher","first-page":"322","DOI":"10.7196\/samj.6077","volume":"103","author":"N Dube","year":"2013","unstructured":"Dube N, Adewusi E, Summers R. Risk of nevirapine-associated Stevens\u2013Johnson syndrome among HIV-infected pregnant women: the Medunsa National Pharmacovigilance Centre, 2007\u20132012. S Afr Med J. 2013;103(5):322\u20135.","journal-title":"S Afr Med J"},{"issue":"4","key":"158_CR147","doi-asserted-by":"publisher","first-page":"e93543","DOI":"10.1371\/journal.pone.0093543","volume":"9","author":"L Knight","year":"2014","unstructured":"Knight L, Muloiwa R, Dlamini S, et al. Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis. PloS One. 2014;9(4):e93543.","journal-title":"PloS One."},{"issue":"7","key":"158_CR148","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2165\/00002018-200427070-00004","volume":"27","author":"N Mittmann","year":"2004","unstructured":"Mittmann N, Knowles SR, Gomez M, et al. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf. 2004;27(7):477\u201387.","journal-title":"Drug Saf."},{"issue":"4","key":"158_CR149","first-page":"839","volume":"20","author":"MP Sanchez-Lopez","year":"2008","unstructured":"Sanchez-Lopez MP, Dresch V. The 12-Item General Health Questionnaire (GHQ-12): reliability, external validity and factor structure in the Spanish population. Psicothema. 2008;20(4):839\u201343.","journal-title":"Psicothema."},{"issue":"5","key":"158_CR150","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic drug\u2013induced cutaneous reactions in Han Chinese. Epilepsia. 2007;48(5):1015\u20138.","journal-title":"Epilepsia."},{"issue":"9","key":"158_CR151","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/cid\/cit021","volume":"56","author":"DF Carr","year":"2013","unstructured":"Carr DF, Chaponda M, Jorgensen AL, et al. Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population. Clin Infect Dis. 2013;56(9):1330\u20139.","journal-title":"Clin Infect Dis."},{"issue":"2","key":"158_CR152","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1542\/peds.2008-1923","volume":"123","author":"N Levi","year":"2009","unstructured":"Levi N, Bastuji-Garin S, Mockenhaupt M, et al. Medications as risk factors of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics. 2009;123(2):e297\u2013304.","journal-title":"Pediatrics."},{"issue":"5","key":"158_CR153","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-4632.2012.05743.x","volume":"52","author":"B Saka","year":"2013","unstructured":"Saka B, Barro-Traore F, Atadokpede FA, et al. Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries. Int J Dermatol. 2013;52(5):575\u20139.","journal-title":"Int J Dermatol."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-015-0158-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0158-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:59:03Z","timestamp":1718128743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-015-0158-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":153,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["158"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0158-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]},"assertion":[{"value":"19 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Roni P. Dodiuk-Gad, Wen-Hung Chung, Laurence Valeyrie-Allanore, and Neil H. Shear have no conflicts of interest\u2014including financial interests, relationships, and affiliations\u2014that are relevant to the subject of this submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}